131 related articles for article (PubMed ID: 24859021)
1. Clinical significance of measuring soluble LR11, a circulating marker of atherosclerosis and HbA1c in familial hypercholesterolemia.
Nohara A; Kobayashi J; Kawashiri MA; Tada H; Inazu A; Jiang M; Mabuchi H; Bujo H
Clin Biochem; 2014 Sep; 47(13-14):1326-8. PubMed ID: 24859021
[TBL] [Abstract][Full Text] [Related]
2. LR11/SorLA links triglyceride-rich lipoproteins to risk of developing cardiovascular disease in FH patients.
Vongpromek R; Bujo H; Hoekstra M; Schneider WJ; van der Zee L; Schinkel AF; Korporaal SJ; Dik WA; Ebinuma H; Jiang M; Verhoeven AJ; Sijbrands EJ; Mulder MT
Atherosclerosis; 2015 Dec; 243(2):429-37. PubMed ID: 26520897
[TBL] [Abstract][Full Text] [Related]
3. Circulating soluble form of LR11, a regulator of smooth muscle cell migration, is a novel marker for intima-media thickness of carotid arteries in type 2 diabetes.
Jin W; Jiang M; Han X; Han X; Murano T; Hiruta N; Ebinuma H; Piao L; Schneider WJ; Bujo H
Clin Chim Acta; 2016 Jun; 457():137-41. PubMed ID: 27095609
[TBL] [Abstract][Full Text] [Related]
4. Soluble LR11 associates with aortic root calcification in asymptomatic treated male patients with familial hypercholesterolemia.
Vongpromek R; Bos S; Ten Kate GR; Bujo H; Jiang M; Nieman K; Schneider W; Roeters van Lennep JE; Verhoeven AJM; Sijbrands EJG; Mulder MT
Atherosclerosis; 2017 Oct; 265():299-304. PubMed ID: 28637586
[TBL] [Abstract][Full Text] [Related]
5. Levels of the soluble LDL receptor-relative LR11 decrease in overweight individuals with type 2 diabetes upon diet-induced weight loss.
Berk KA; Vongpromek R; Jiang M; Schneider WJ; Timman R; Verhoeven AJ; Bujo H; Sijbrands EJ; Mulder MT
Atherosclerosis; 2016 Nov; 254():67-72. PubMed ID: 27697674
[TBL] [Abstract][Full Text] [Related]
6. Development of an immunoassay for the quantification of soluble LR11, a circulating marker of atherosclerosis.
Matsuo M; Ebinuma H; Fukamachi I; Jiang M; Bujo H; Saito Y
Clin Chem; 2009 Oct; 55(10):1801-8. PubMed ID: 19661140
[TBL] [Abstract][Full Text] [Related]
7. Enhanced circulating soluble LR11 in patients with diabetic retinopathy.
Takahashi M; Bujo H; Shiba T; Jiang M; Maeno T; Shirai K
Am J Ophthalmol; 2012 Jul; 154(1):187-92. PubMed ID: 22541650
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of circulating soluble LR11 on long-term clinical outcomes in patients with coronary artery disease.
Ogita M; Miyauchi K; Kasai T; Tsuboi S; Wada H; Naito R; Konishi H; Dohi T; Tamura H; Okazaki S; Yanagisawa N; Shimada K; Suwa S; Jiang M; Bujo H; Daida H
Atherosclerosis; 2016 Jan; 244():216-21. PubMed ID: 26687467
[TBL] [Abstract][Full Text] [Related]
9. Enhanced circulating soluble LR11 in patients with coronary organic stenosis.
Takahashi M; Bujo H; Jiang M; Noike H; Saito Y; Shirai K
Atherosclerosis; 2010 Jun; 210(2):581-4. PubMed ID: 20047743
[TBL] [Abstract][Full Text] [Related]
10. Levels of circulating soluble LR11, a regulator of smooth muscle cell migration, are highly associated with atherosclerotic plaques in patients with carotid artery stenosis.
Harada M; Jiang M; Terai K; Ebinuma H; Hiruta N; Schneider WJ; Sugo N; Nagao T; Bujo H
Clin Chim Acta; 2019 Mar; 490():69-76. PubMed ID: 30550937
[TBL] [Abstract][Full Text] [Related]
11. Increased circulating soluble LR11 in patients with acute coronary syndrome.
Ogita M; Miyauchi K; Dohi T; Tsuboi S; Miyazaki T; Yokoyama T; Yokoyama K; Shimada K; Kurata T; Jiang M; Bujo H; Daida H
Clin Chim Acta; 2013 Jan; 415():191-4. PubMed ID: 23127357
[TBL] [Abstract][Full Text] [Related]
12. Soluble LR11 is a novel biomarker for vascular lesions late after Kawasaki disease.
Watanabe K; Suzuki H; Jiang M; Haniu H; Numano F; Hoshina S; Saitoh A; Uchiyama M; Bujo H
Atherosclerosis; 2016 Mar; 246():94-7. PubMed ID: 26761773
[TBL] [Abstract][Full Text] [Related]
13. Circulating soluble LR11, a novel marker of smooth muscle cell proliferation, is enhanced after coronary stenting in response to vascular injury.
Ogita M; Miyauchi K; Jiang M; Kasai T; Tsuboi S; Naito R; Konishi H; Dohi T; Yokoyama T; Okazaki S; Shimada K; Bujo H; Daida H
Atherosclerosis; 2014 Nov; 237(1):374-8. PubMed ID: 25443876
[TBL] [Abstract][Full Text] [Related]
14. Circulating LR11 is a novel soluble-receptor marker for early-stage clinical conditions in patients with non-Hodgkin's lymphoma.
Fujimura K; Ebinuma H; Fukamachi I; Ohwada C; Kawaguchi T; Shimizu N; Takeuchi M; Sakaida E; Jiang M; Nakaseko C; Bujo H
Clin Chim Acta; 2014 Mar; 430():48-54. PubMed ID: 24394293
[TBL] [Abstract][Full Text] [Related]
15. Circulating soluble LR11, a differentiation regulator for vascular cells, is increased during pregnancy and exaggerated in patients with pre-eclampsia.
Ishida H; Jiang M; Ebinuma H; Hiruta N; Schneider WJ; Kinoshita T; Bujo H
Clin Chim Acta; 2019 Oct; 497():172-177. PubMed ID: 31299181
[TBL] [Abstract][Full Text] [Related]
16. Genotypic and phenotypic features in homozygous familial hypercholesterolemia caused by proprotein convertase subtilisin/kexin type 9 (PCSK9) gain-of-function mutation.
Mabuchi H; Nohara A; Noguchi T; Kobayashi J; Kawashiri MA; Inoue T; Mori M; Tada H; Nakanishi C; Yagi K; Yamagishi M; Ueda K; Takegoshi T; Miyamoto S; Inazu A; Koizumi J;
Atherosclerosis; 2014 Sep; 236(1):54-61. PubMed ID: 25014035
[TBL] [Abstract][Full Text] [Related]
17. Association Between Cholesterol Efflux Capacity and Atherosclerotic Cardiovascular Disease in Patients With Familial Hypercholesterolemia.
Ogura M; Hori M; Harada-Shiba M
Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):181-8. PubMed ID: 26543100
[TBL] [Abstract][Full Text] [Related]
18. Vitreous fluid and circulating levels of soluble lr11, a novel marker for progression of diabetic retinopathy.
Shiba T; Bujo H; Takahashi M; Sato Y; Jiang M; Hori Y; Maeno T; Shirai K
Graefes Arch Clin Exp Ophthalmol; 2013 Dec; 251(12):2689-95. PubMed ID: 23652469
[TBL] [Abstract][Full Text] [Related]
19. Soluble LR11 competes with amyloid β in binding to cerebrospinal fluid-high-density lipoprotein.
Yano K; Hirayama S; Misawa N; Furuta A; Ueno T; Motoi Y; Seino U; Ebinuma H; Ikeuchi T; Schneider WJ; Bujo H; Miida T
Clin Chim Acta; 2019 Feb; 489():29-34. PubMed ID: 30448281
[TBL] [Abstract][Full Text] [Related]
20. The soluble form of LR11 protein is a regulator of hypoxia-induced, urokinase-type plasminogen activator receptor (uPAR)-mediated adhesion of immature hematological cells.
Nishii K; Nakaseko C; Jiang M; Shimizu N; Takeuchi M; Schneider WJ; Bujo H
J Biol Chem; 2013 Apr; 288(17):11877-86. PubMed ID: 23486467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
